Detalhe da pesquisa
1.
Unexpected CD4 decay, hidden adherence gaps, resilience, and the need for long-acting therapy in a single HIV outpatients' cohort.
AIDS Care
; : 1-6, 2024 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38170878
2.
Concomitant diagnosis of sexually transmitted infections and human monkeypox in patients attending a sexual health clinic in Milan, Italy.
J Med Virol
; 95(1): e28328, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36415133
3.
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort.
HIV Med
; 22(9): 843-853, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34318591
4.
Short-term inhibition of SARS-CoV-2 by hydrogen peroxide in persistent nasopharyngeal carriers.
J Med Virol
; 93(3): 1766-1769, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32881014
5.
Emerging drugs for the treatment of HIV/AIDS: a review of 2019/2020 phase II and III trials.
Expert Opin Emerg Drugs
; 26(3): 219-230, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34176425
6.
Dolutegravir Plus Rilpivirine as a Switch Option in cART-Experienced Patients: 96-Week Data.
Ann Pharmacother
; 52(8): 740-746, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29482352
7.
A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks' observational data.
BMC Infect Dis
; 17(1): 658, 2017 09 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-28964268
8.
Impressive Boosting of Anti-S1/S2 Immunoglobulin G Production in Coronavirus Disease 2019 (COVID-19)-experienced Patients After the First Shot of the BNT162b2 Messenger RNA COVID-19 Vaccine.
Clin Infect Dis
; 73(6): e1402-e1403, 2021 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33693610
9.
Shall We Dance? Extending TANGO's Results to Clinical Practice.
Clin Infect Dis
; 71(7): e200-e201, 2020 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32198516
10.
OPERA: responses to peginterferon and ribavirin therapy in a subgroup of interferon-naïve patients with HIV/HCV genotype 2/3 co-infection in Italy.
Liver Int
; 35(1): 120-9, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25041136
11.
Comparison of the pharmacokinetics of raltegravir given at 2 doses of 400 mg by swallowing versus one dose of 800 mg by chewing in healthy volunteers: a randomized, open-label, 2-period, single-dose, crossover phase 1 study.
Ther Drug Monit
; 37(1): 119-25, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24988438
12.
Nanoformulation of antiretroviral drugs enhances their penetration across the blood brain barrier in mice.
Nanomedicine
; 11(6): 1387-97, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25839392
13.
Analysis and clinical determinants of post-COVID-19 syndrome in the Lombardy region: evidence from a longitudinal cohort study.
BMJ Open
; 14(2): e075185, 2024 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38320835
14.
Duration of first-line antiretroviral therapy with tenofovir and emtricitabine combined with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir in the Italian ARCA cohort.
J Antimicrob Chemother
; 68(1): 200-5, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22915463
15.
Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy-treated immunologic nonresponders.
Blood
; 118(12): 3263-72, 2011 Sep 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-21576701
16.
Efficacy and Durability of Dolutegravir- or Darunavir-Based Regimens in ART-Naïve AIDS- or Late-Presenting HIV-Infected Patients.
Viruses
; 15(5)2023 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37243208
17.
Effects of ritonavir and cobicistat on dolutegravir exposure: when the booster can make the difference.
J Antimicrob Chemother
; 72(6): 1842-1844, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28333266
18.
Evaluation of the immune benefits of two probiotic strains Bifidobacterium animalis ssp. lactis, BB-12® and Lactobacillus paracasei ssp. paracasei, L. casei 431® in an influenza vaccination model: a randomised, double-blind, placebo-controlled study.
Br J Nutr
; 107(6): 876-84, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21899798
19.
The future of long-acting cabotegravir plus rilpivirine therapy: deeds and misconceptions.
Int J Antimicrob Agents
; 60(3): 106627, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35760225
20.
Decay rate of antiS1/S2 IgG serum levels after 6 months of BNT162b2 vaccination in a cohort of COVID-19-naive and COVID-19-experienced subjects.
Hum Vaccin Immunother
; 18(5): 2060018, 2022 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35511791